Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver
about
Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3FPolycomb repressor complex 2 regulates HOXA9 and HOXA10, activating ID2 in NK/T-cell lines.Recent In Vivo Evidences of Particle-Based Delivery of Small-Interfering RNA (siRNA) into Solid TumorsTargeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.Negative energy balance and hepatic gene expression patterns in high-yielding dairy cows during the early postpartum period: a global approach.A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets.Id2 deletion attenuates Apc-deficient ileal tumor formation.The Wnt/β-catenin signaling/Id2 cascade mediates the effects of hypoxia on the hierarchy of colorectal-cancer stem cellsA short-term colorectal cancer sphere culture as a relevant tool for human cancer biology investigation.Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases.Lipidic systems for in vivo siRNA delivery.Potential clinical applications of siRNA technique: benefits and limitations.Bone morphogenetic protein type I receptor antagonists decrease growth and induce cell death of lung cancer cell lines.Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression.A distinct spectrum of copy number aberrations in pediatric high-grade gliomas.RNA sequencing supports distinct reactive oxygen species-mediated pathways of apoptosis by high and low size mass fractions of Bay leaf (Lauris nobilis) in HT-29 cells.Id2 Collaborates with Id3 To Suppress Invariant NKT and Innate-like Tumors.
P2860
Q33820517-E2EF701D-3D77-485B-9255-9B5EDCE224D5Q33951701-31662EC3-6C91-4AD6-90ED-7CC52F2AC493Q34165321-E46D5CD9-5BCF-4EB9-8B23-A31888E76327Q34420393-1DBF6620-A837-4F65-AD87-A339AF603818Q34432736-2149D3C4-3FA8-4E3E-A92D-022663049102Q34433320-13D7C673-C3D3-4C03-80EA-778DEA972694Q35973324-F02B573A-2F60-41D4-8C73-3E7C8EF57323Q36674940-8F4CB578-3386-457B-9FAB-04FD111D144BQ36889620-F3C3CB87-EF11-404A-A11F-6F8D2D81FD41Q37407384-272489EB-9102-4038-934B-308861529DFCQ37598096-69859AFF-9493-4787-A076-A591B5F6D919Q37801965-2C79BC86-2EF4-4DFC-A3CE-3CB1941AE52EQ39164711-5C41D9A2-8703-42F1-8D10-04A5E7AC3BC5Q39196669-38601DE8-82B8-4ACC-996E-A6E2BB871AA8Q41943655-F7874188-241D-44F6-B36F-FF2D17CF931BQ46709248-F5F4DF01-128A-4FAD-9FC5-4A915DE8DD8DQ48166027-6FF5526A-4AA8-47CB-BB8D-6A35422860E1
P2860
Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Therapeutic targeting of Id2 r ...... carcinoma in the murine liver
@ast
Therapeutic targeting of Id2 r ...... carcinoma in the murine liver
@en
type
label
Therapeutic targeting of Id2 r ...... carcinoma in the murine liver
@ast
Therapeutic targeting of Id2 r ...... carcinoma in the murine liver
@en
prefLabel
Therapeutic targeting of Id2 r ...... carcinoma in the murine liver
@ast
Therapeutic targeting of Id2 r ...... carcinoma in the murine liver
@en
P2093
P2860
P356
P1433
P1476
Therapeutic targeting of Id2 r ...... carcinoma in the murine liver
@en
P2093
A M Sanguino
G E Gallick
G Lopez-Berestein
G Van Buren
L S Mangala
P2860
P2888
P304
P356
10.1038/ONC.2008.356
P407
P577
2008-09-22T00:00:00Z